XML 39 R24.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Equity Compensation Plans | 6 Months Ended
--- | ---
Jun. 30, 2024
Equity Compensation Plans [Abstract] |
Equity Compensation Plans | 18. Equity Compensation Plans 2017 Equity Incentive Plan The Purple Innovation, Inc. 2017 Equity Incentive Plan (the “2017 Plan”) provides for grants of stock options, stock appreciation rights, restricted stock units and other stock-based awards. Directors, officers and other employees, as well as others performing consulting or advisory services for the Company and its subsidiaries, will be eligible for grants under the 2017 Plan. As of June 30, 2024, an aggregate of 2.2 million shares remain available for issuance or use under the 2017 Plan. Employee Stock Options The following table summarizes the Company’s total stock option activity for the six months ended June 30, 2024:
|  | Options (in thousands) |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term in Years |  |  | Intrinsic Value (in thousands) |
Options outstanding as of January 1, 2024 |  |  | 863 |  |  | $ | 8.13 |  |  |  | 2.2 |  |  | $ | — |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | (309 | ) |  |  | 9.69 |  |  |  | — |  |  |  | — |
Options outstanding as of June 30, 2024 |  |  | 554 |  |  | $ | 7.27 |  |  |  | 2.6 |  |  | $ | — |
Outstanding and exercisable stock options as of June 30, 2024 are as follows:
|  |  | Options Outstanding |  |  | Options Exercisable |
Exercise Prices |  |  | Number of Options Outstanding (in thousands) |  |  | Weighted Average Remaining Life (Years) |  |  | Number of Options Exercisable (in thousands) |  |  | Weighted Average Remaining Life (Years) |  |  | Intrinsic Value (in thousands) |
$ | 6.82 |  |  |  | 500 |  |  |  | 2.8 |  |  |  | 333 |  |  |  | 2.8 |  |  | $ | — |
| 7.99 |  |  |  | 19 |  |  |  | 0.4 |  |  |  | 19 |  |  |  | 0.4 |  |  |  | — |
| 13.12 |  |  |  | 35 |  |  |  | 0.9 |  |  |  | 35 |  |  |  | 0.9 |  |  |  | — |
The following table summarizes the Company’s unvested stock option activity for the six months ended June 30, 2024:
|  | Options (in thousands) |  |  | Weighted Average Grant Date Fair Value |
Nonvested options as of January 1, 2024 |  |  | 337 |  |  | $ | 0.41 |
Granted |  |  | — |  |  |  | — |
Vested |  |  | (170 | ) |  |  | 0.59 |
Forfeited |  |  | — |  |  |  | — |
Nonvested options as of June 30, 2024 |  |  | 167 |  |  | $ | 0.22 |
The estimated fair value of Company stock options is amortized over the options vesting period on a straight-line basis. For the three and six months ended June 30, 2023, the Company recognized stock option expense of $0.1 million and $0.4 million, respectively. Stock option expense was de minimis for the three and six months ended June 30, 2024. As of June 30, 2024, outstanding stock options had a de minimis amount of unrecognized stock compensation cost with a remaining recognition period of 0.8 years. The fair value of stock options vested during the six months ended June 30, 2024 totaled $0.1 million. Employee Restricted Stock Units During the first six months of 2024, the Company granted 1.8 million restricted stock units under the 2017 Equity Incentive Plan to certain members of the Company’s management team. Of the restricted stock units granted, 0.4 million included a market vesting condition. The restricted stock awards that did not have a market vesting condition had a weighted average grant date fair value of $1.00 per share. The estimated fair value of these awards is recognized on a straight-line basis over the vesting period. For those awards that include a market vesting condition, the estimated fair value of the restricted stock was measured on the grant date and incorporated the probability of vesting occurring. The estimated fair value is recognized over the derived service period (as determined by the valuation model), with such recognition occurring regardless of whether the market condition is met. The Company determined the weighted average grant date fair value of the awards with the market vesting condition to be $1.13 per share using a Monte Carlo Simulation model with the following weighted average assumptions:
Trading price of common stock on measurement date |  | $ | 1.50 |
Risk free interest rate |  |  | 4.46 | %
Expected life in years |  |  | 3.0 |
Expected volatility |  |  | 97.1 | %
Expected dividend yield |  |  | — |
The following table summarizes the Company’s restricted stock unit activity for the six months ended June 30, 2024:
|  | Number Outstanding (in thousands) |  |  | Weighted Average Grant Date Fair Value |
Nonvested restricted stock units as of January 1, 2024 |  |  | 3,057 |  |  | $ | 2.97 |
Granted |  |  | 1,828 |  |  |  | 1.03 |
Vested |  |  | (582 | ) |  |  | 3.87 |
Forfeited |  |  | (260 | ) |  |  | 3.44 |
Nonvested restricted stock units as of June 30, 2024 |  |  | 4,043 |  |  | $ | 1.94 |
The Company recorded restricted stock unit expense of $0.8 million and $1.3 million during the three and six months ended June 30, 2024, respectively, and $0.9 million and $1.8 million during the three and six months ended June 30, 2023, respectively. As of June 30, 2024, outstanding restricted stock units had $5.2 million of unrecognized stock compensation cost with a remaining recognition period of 1.6 years. Aggregate Non-Cash Stock-Based Compensation The Company has accounted for all stock-based compensation under the provisions of ASC 718 Compensation—Stock Compensation. This standard requires the Company to record a non-cash expense associated with the fair value of stock-based compensation over the requisite service period. The following table summarizes the aggregate non-cash stock-based compensation recognized in the statement of operations for stock awards, employee stock options and employee restricted stock units (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Cost of revenues |  | $ | 103 |  |  | $ | 23 |  |  | $ | 190 |  |  | $ | 98 |
Marketing and sales |  |  | 128 |  |  |  | 240 |  |  |  | 224 |  |  |  | 215 |
General and administrative |  |  | 514 |  |  |  | 1,332 |  |  |  | 755 |  |  |  | 2,452 |
Research and development |  |  | 80 |  |  |  | 66 |  |  |  | 148 |  |  |  | 88 |
Total non-cash stock-based compensation |  | $ | 825 |  |  | $ | 1,661 |  |  | $ | 1,317 |  |  | $ | 2,853 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration